Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 13, 2024
Dissecting Acute Drug-Induced Hepatotoxicity and Therapeutic Responses of Steatotic Liver Disease Using Primary Mouse Liver and Blood Cells in a Liver-On-A-Chip ModelHanyang Liu, Guo Yin, Marlene Sophia Kohlhepp, et al.
Gut|May 12, 2019
Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitisOliver Krenkel, Jana Hundertmark, Ali T Abdallah, et al.
Physical Review Letters|March 23, 2002
Band structure and density of States effects in co-based magnetic tunnel junctionsP LeClair, J T Kohlhepp, C H van De Vin, et al.
Gut|April 8, 2025
Reactive cholangiocyte-derived ORM2 drives a pathogenic modulation of the injured biliary niche through macrophage reprogrammingHanyang Liu, Guo Yin, Bianca Franco Leonardi, et al.
JHEP Reports : Innovation in Hepatology|January 19, 2026
Effects of hypothermic oxygenated machine perfusion on bile composition after liver transplantation - Findings from a randomized controlled trialFrederik Schliephake, Isabella Lurje, Deniz Uluk, et al.
Hepatology (Baltimore, Md.)|March 27, 2015
Liver inflammation abrogates immunological tolerance induced by Kupffer cellsFelix Heymann, Julia Peusquens, Isis Ludwig-Portugall, et al.
Gastroenterology|February 3, 2019
CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4<sup>+</sup> T-Cell-Dependent Control of SenescenceJana C Mossanen, Marlene Kohlhepp, Alexander Wehr, et al.
Journal of Clinical Medicine|April 23, 2020
The Medium-Chain Fatty Acid Receptor GPR84 Mediates Myeloid Cell Infiltration Promoting Steatohepatitis and FibrosisTobias Puengel, Steve De Vos, Jana Hundertmark, et al.
International Journal of Molecular Sciences|June 24, 2022
Combined Therapy with a CCR2/CCR5 Antagonist and FGF21 Analogue Synergizes in Ameliorating Steatohepatitis and FibrosisTobias Puengel, Sander Lefere, Jana Hundertmark, et al.
Egastroenterology|June 3, 2026
TERT rs10069690 variant is linked to reduced cholangiocarcinoma incidence but adverse prognosis in patients undergoing resectionIsabella Lurje, Justus Pein, Paul Horn, et al.
Pageof 13